Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
WhiteLab Genomics logo — Unleash the Potential of Genomic Medicine Using AI

WhiteLab Genomics

Unleash the Potential of Genomic Medicine Using AI

Founded 2019 France France 56 employees Seed Total: $10.50M AI, Biotechnology

General Information

Company Name WhiteLab Genomics
Founded Year 2019
Location France France
Employees 56
Industries AI, Biotechnology
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Project Based, Licensing
Social

BounceWatch is an independent company data service, not affiliated with WhiteLab Genomics. To contact WhiteLab Genomics, visit whitelabgx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does WhiteLab Genomics compare?

A PDF of WhiteLab Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting WhiteLab Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 05, 2026

WhiteLab Genomics is attending London Life Sciences Week and the Jefferies Global Healthcare Conference.

Raising Funds Nov 04, 2026

WhiteLab Genomics raised a $26M Series B round led by AVP.

Market Expansion Nov 04, 2026

WhiteLab Genomics traveled to Seoul to build relationships with Korean partners and investors.

Key Hire Nov 04, 2026

Artemis Llamosi joined WhiteLab Genomics as CTO.

Board Appointment Nov 04, 2026

François Robinet joined WhiteLab Genomics' Board of Directors.

New Partnership Oct 26, 2026

WhiteLab Genomics collaborated with Dr. Francoise Piguet and the GENOV Innovation Unit at the Paris Brain Institute for in vivo validation.

WhiteLab Genomics a competitor of yours? Have our desk watch it

About WhiteLab Genomics

WhiteLab Genomics, founded in 2019, represents a cutting-edge integration of AI and Biotechnology. With headquarters in France and additional offices in Paris, Boston, and Montréal, the company leverages artificial intelligence to revolutionize genomic medicine.

WhiteLab's unique AI platform facilitates the design and optimization of delivery systems, targeting a wide array of therapeutic areas such as oncology, neurology, ophthalmology, and rare diseases. Their collaborations with prominent firms like Sanofi, Cytiva, and Debiopharm underscore the company's credibility and industry impact.

Notably backed by Y Combinator and the French Tech 2030 program, WhiteLab secured a $10.00M Seed Round investment on 12 September 2022, with financial support from renowned investors including Omnes Capital and Debiopharm Group. WhiteLab Genomics stands as a promising player in the TechBio space, poised for substantial impact in genomic medicine.

Business keywords: Genomic Medicine, TechBio, Computational Biology, Structural Biology, Viral Vectors, Non-Viral Vectors, RNA Payloads, DNA Payloads, Pharmaceutical Partnerships, Therapeutic Design, Graph Knowledge Technology, Preclinical Development, Genomic Therapy Optimization

Services & Products

AI-Led Framework for Drug Design
Development of Genomic Medicines
Optimization of Delivery Vehicles for Nucleic Acid Medicines
Identification of Target Receptors
Payload Design
In Silico Design and Wet Lab Validation

Target Customers

Pharmaceutical Companies Biotechnology Firms Research Institutions Oncology Centers Neuroscience Departments Ophthalmology Units Rare Disease Researchers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $10.00M 3
Y Combinator Omnes Capital
Y Combinator, Omnes Capital +1
12 Sep 2022
Pre Seed Round $500.00K 1
Y Combinator
Y Combinator
29 Mar 2022

WhiteLab Genomics Alternatives & Competitors

View All Alternatives
WhiteLab Genomics vs
Antiverse
Antiverse United Kingdom

Designing functional antibodies for the most challenging targets.

Series A
34 employees
AI, Biotechnology
Compare WhiteLab Genomics vs Antiverse
WhiteLab Genomics vs
Cellular Intelligence
Cellular Intelligence United States

Cellular Intelligence

Series A
91 employees
AI, Biotechnology
WhiteLab Genomics vs
Moonwalk Biosciences
Moonwalk Biosciences United States

Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and epigenetic i...

Series A
21 employees
AI, Biopharma
View all alternatives

FAQ About WhiteLab Genomics

Unleash the Potential of Genomic Medicine Using AI
WhiteLab Genomics was founded in 2019.
WhiteLab Genomics is headquartered in France.
WhiteLab Genomics operates in AI and Biotechnology. Its work centres on Genomic Medicine, TechBio, Computational Biology and Structural Biology. Its customers include Pharmaceutical Companies, Biotechnology Firms and Research Institutions.
WhiteLab Genomics has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Project Based and Licensing.
WhiteLab Genomics has approximately 56 employees.
WhiteLab Genomics has completed 2 funding rounds, raising a total of $10.50M. The latest funding stage is Seed.
WhiteLab Genomics offers: AI-Led Framework for Drug Design, Development of Genomic Medicines, Optimization of Delivery Vehicles for Nucleic Acid Medicines, Identification of Target Receptors, Payload Design, In Silico Design and Wet Lab Validation.
Top alternatives and competitors to WhiteLab Genomics include Antiverse, Cellular Intelligence, Moonwalk Biosciences, Standigm, Phenomic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WhiteLab Genomics and Antiverse are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for WhiteLab Genomics, https://bouncewatch.com/company/whitelab-genomics, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout